ES2102420T3 - Metodo para la produccion de albumina de suero humano. - Google Patents

Metodo para la produccion de albumina de suero humano.

Info

Publication number
ES2102420T3
ES2102420T3 ES92104625T ES92104625T ES2102420T3 ES 2102420 T3 ES2102420 T3 ES 2102420T3 ES 92104625 T ES92104625 T ES 92104625T ES 92104625 T ES92104625 T ES 92104625T ES 2102420 T3 ES2102420 T3 ES 2102420T3
Authority
ES
Spain
Prior art keywords
human serum
production
serum albumine
guest
cultivation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92104625T
Other languages
English (en)
Spanish (es)
Inventor
Kaoru Kobayashi
Shinobu Kuwae
Tomoshi Ooya
Hirotoshi Fukutsuka
Akinori Sumi
Wataru Ohtani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of ES2102420T3 publication Critical patent/ES2102420T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ES92104625T 1991-03-20 1992-03-18 Metodo para la produccion de albumina de suero humano. Expired - Lifetime ES2102420T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3081719A JPH0671432B2 (ja) 1991-03-20 1991-03-20 ヒト血清アルブミンの製造方法

Publications (1)

Publication Number Publication Date
ES2102420T3 true ES2102420T3 (es) 1997-08-01

Family

ID=13754223

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92104625T Expired - Lifetime ES2102420T3 (es) 1991-03-20 1992-03-18 Metodo para la produccion de albumina de suero humano.

Country Status (9)

Country Link
US (1) US5334512A (OSRAM)
EP (1) EP0504823B1 (OSRAM)
JP (1) JPH0671432B2 (OSRAM)
KR (1) KR100218853B1 (OSRAM)
CA (1) CA2063511C (OSRAM)
DE (1) DE69220113T2 (OSRAM)
DK (1) DK0504823T3 (OSRAM)
ES (1) ES2102420T3 (OSRAM)
TW (1) TW198683B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
CA2136564C (en) * 1993-11-26 2008-04-08 Kaoru Kobayashi Process for producing human serum albumin
JPH07308199A (ja) 1994-05-18 1995-11-28 Green Cross Corp:The ヒト血清アルブミンの製造方法
PL335975A1 (en) 1997-04-03 2000-06-05 Yoshitomi Pharmaceutical Method of obtaining a heterologous protein
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
US8263401B2 (en) * 2004-05-26 2012-09-11 University Of Medicine And Dentistry Of New Jersey Adenylyl cyclase antibodies, compositions and uses thereof
WO2006066595A2 (en) * 2004-12-22 2006-06-29 Novozymes A/S Recombinant production of serum albumin
NZ602479A (en) 2008-05-15 2013-05-31 R Tech Ueno Ltd Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
CA3047523A1 (en) * 2016-12-21 2018-06-28 Prometic Biosciences Inc. Methods and compositions for preventing or minimizing epithelial-mesenchymal transition
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US12151045B2 (en) 2020-12-28 2024-11-26 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
KR20240032272A (ko) 2022-09-02 2024-03-12 조신아 아동원예지도사 교육방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
EP0079739A3 (en) * 1981-11-12 1984-08-08 The Upjohn Company Albumin-based nucleotides, their replication and use, and plasmids for use therein
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
EP0206733A1 (en) * 1985-06-17 1986-12-30 Genex Corporation Cloned human serum albumin gene
DK13087A (da) * 1986-01-13 1987-07-14 Genex Corp Gensekvens til fremstilling af human serumalbumin i bacillus
GB8613388D0 (en) * 1986-06-03 1986-07-09 Delta Biotechnology Ltd Induction of galactose regulated gene expression in yeast
GB8615701D0 (en) * 1986-06-27 1986-08-06 Delta Biotechnology Ltd Stable gene integration vector
JPS6460370A (en) * 1987-05-27 1989-03-07 Sankyo Co High-temperature culture of yeast
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
JP2791418B2 (ja) * 1987-12-02 1998-08-27 株式会社ミドリ十字 異種蛋白質の製造方法、組換えdna、形質転換体
JPH01240191A (ja) * 1988-02-16 1989-09-25 Green Cross Corp:The 酵母で機能する新規シグナルペプチドおよびこれを用いた異種蛋白質の分泌発現
IL89992A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of human serum albumin in methylotrophic yeasts
GB8820951D0 (en) * 1988-09-07 1988-10-05 Delta Biotechnology Ltd Fermentation method
CA2017176A1 (en) * 1989-05-22 1990-11-22 Yoshitomi Pharmaceutical Industries Ltd. Albumin gene-containing plasmid, transformant carrying same, production of such transformant and production of albumin
JP2855130B2 (ja) * 1989-07-19 1999-02-10 吉富製薬株式会社 異種蛋白発現用融合酵母菌、該菌の製造方法および異種蛋白の製造方法
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法

Also Published As

Publication number Publication date
DE69220113D1 (de) 1997-07-10
EP0504823A3 (en) 1993-04-07
EP0504823A2 (en) 1992-09-23
DE69220113T2 (de) 1997-09-25
TW198683B (OSRAM) 1993-01-21
KR100218853B1 (ko) 1999-10-01
CA2063511A1 (en) 1992-09-21
CA2063511C (en) 2001-11-27
JPH04293495A (ja) 1992-10-19
US5334512A (en) 1994-08-02
EP0504823B1 (en) 1997-06-04
KR920018218A (ko) 1992-10-21
JPH0671432B2 (ja) 1994-09-14
DK0504823T3 (da) 1997-06-23

Similar Documents

Publication Publication Date Title
ES2102420T3 (es) Metodo para la produccion de albumina de suero humano.
LV12189A (lv) Panemiens N-amino-1-hidroksialkiliden-1,1-bifosfon-skabju iegusanai
DE69132370D1 (de) Methode zur herstellung von eicosapentansäuren
GR3006068T3 (OSRAM)
DE3854080D1 (de) Verfahren zur Herstellung von Bis-homo-gamma-linolensäure.
GR3026216T3 (en) Process for production of 8,11-eicosadienoic acid
HUT52821A (en) Process for producing optically active 2-arylpropionic acids
DE69220746D1 (de) Verfahren zur Herstellung einer mehrfach ungesättigten Fettsäure des Omega 9 Typs
ES8200401A1 (es) Un procedimiento para la preparacion de una composicion de un inhibidor de hmg-coa reductasa y un secuestrante de acidosbiliares util para el tratamiento de la hipercolesteremia.
ES2177649T3 (es) Procedimiento para el fraccionamiento de la vinaza.
ATE14219T1 (de) Verfahren zur herstellung von 3-oxonitrilen.
ATE140722T1 (de) Triglyceridfraktionierung
DE3579080D1 (de) Verfahren zur herstellung eines kristallinen koerpers aus der schmelze.
ES2039451T5 (es) Procedimiento para la produccion de acido araquidonico.
ES2038750T3 (es) Un procedimiento para preparar 9-etil-6,9-dihidro-4,6-dioxo-10-propil-4h-pirano(3,2-g)-quinolina-2,8-dicarboxilato calcico.
ATE164190T1 (de) Verfahren zur herstellung von butantetracarboxylat
DE69401979D1 (de) Verfahren zur Herstellung von L-(-)-Carnitin aus Abfallprodukten mit entgegengesetzter Konfiguration
DE68912236D1 (de) Verfahren zur Herstellung von hochgradig ungesättigten Fettsäuren.
DE68924492D1 (de) Verfahren zur Herstellung von mehrfach ungesättigten Fettsäuren mit ungerader Zahl von Kohlenstoffatomen.
IL63469A0 (en) Cephalosporin derivatives,their production and their uses
KR890005476A (ko) 빙핵 형성 미생물을 이용한 얼음의 제조방법
ES2027775T3 (es) Procedimiento de cultivo de champinones sobre abono compuesto.
ES2039525T3 (es) Metodo perfeccionado para la preparacion de anilinofumarato.
MX3301E (es) Procedimiento para preparar un derivado de prostaglandina
ES2015295B3 (es) Procedimiento para fabricar acidos aldonicos o sus sales

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 504823

Country of ref document: ES